BR112017023636A2 - suplemento dietético - Google Patents

suplemento dietético

Info

Publication number
BR112017023636A2
BR112017023636A2 BR112017023636A BR112017023636A BR112017023636A2 BR 112017023636 A2 BR112017023636 A2 BR 112017023636A2 BR 112017023636 A BR112017023636 A BR 112017023636A BR 112017023636 A BR112017023636 A BR 112017023636A BR 112017023636 A2 BR112017023636 A2 BR 112017023636A2
Authority
BR
Brazil
Prior art keywords
dietary supplement
bifid
genera
lactobacillus
relates
Prior art date
Application number
BR112017023636A
Other languages
English (en)
Other versions
BR112017023636B1 (pt
Inventor
BOURQUI Bertrand
Alberto Habeych Narvaez Edwin
Silva Zolezzi Irma
Galaffu Nicola
Colombo MOTTAZ Sara
Moille Sophie
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53434227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017023636(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112017023636A2 publication Critical patent/BR112017023636A2/pt
Publication of BR112017023636B1 publication Critical patent/BR112017023636B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção refere-se a uma composição oral que compreende ao menos uma bactéria probiótica selecionada dentre os gêneros: lactobacilo, bactérias bífidas e bacilo, e pirofosfato férrico.
BR112017023636-2A 2015-06-11 2016-06-09 Composição oral BR112017023636B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15171552 2015-06-11
EP15171552.1 2015-06-11
PCT/EP2016/063170 WO2016198528A1 (en) 2015-06-11 2016-06-09 Dietary supplement

Publications (2)

Publication Number Publication Date
BR112017023636A2 true BR112017023636A2 (pt) 2018-07-17
BR112017023636B1 BR112017023636B1 (pt) 2021-11-03

Family

ID=53434227

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017023636-2A BR112017023636B1 (pt) 2015-06-11 2016-06-09 Composição oral

Country Status (9)

Country Link
US (2) US11660322B2 (pt)
EP (1) EP3307290B1 (pt)
CN (1) CN107690332A (pt)
BR (1) BR112017023636B1 (pt)
CA (1) CA2983685A1 (pt)
ES (1) ES2803175T3 (pt)
MX (1) MX2017015674A (pt)
PH (1) PH12017502042A1 (pt)
WO (1) WO2016198528A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019012965A2 (pt) 2016-12-22 2019-11-26 Univ Of Otago uso de bactérias do ácido láctico para tratar ou prevenir diabetes mellitus gestacional
EP4136985A1 (en) * 2016-12-22 2023-02-22 University of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
JP7210032B2 (ja) 2017-06-02 2023-01-23 ユニバーシティ オブ オタゴ 産後うつ病及び産後不安の少なくとも１つを治療する又は予防するための乳酸菌の使用
IT201800004072A1 (it) * 2018-03-29 2019-09-29 Smart Farma S R L Composizione alimentare come coadiuvante nello sviluppo della microflora intestinale e del sistema immunitario dei neonati
WO2021153199A1 (ja) * 2020-01-31 2021-08-05 太陽化学株式会社 鉄含有組成物
EP4292442A1 (en) * 2022-06-13 2023-12-20 Ekaterra Research and Development UK Limited An iron fortified instant beverage composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3159931B2 (ja) 1997-02-14 2001-04-23 株式会社ヤクルト本社 鉄分を強化した発酵乳およびその製造方法
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
CA2347891A1 (en) 1999-08-26 2001-03-08 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and/or synbiotics
EP1901771A2 (en) * 2005-06-24 2008-03-26 N-Zymeceuticals, Inc. Nattokinase for reducing whole blood viscosity
ATE473638T1 (de) 2007-03-20 2010-07-15 Unilever Nv Verfahren zur herstellung eines essbaren kulturprodukts mit mehrfach ungesättigten omega-3-fettsäuren und eisen
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
CA2719719A1 (en) * 2008-03-28 2009-10-01 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
EP2258217A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
CN101601421A (zh) 2009-07-04 2009-12-16 内蒙古蒙牛乳业（集团）股份有限公司 一种强化铁和锌的儿童酸奶及其制备方法
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
JP5615285B2 (ja) 2010-03-18 2014-10-29 森永乳業株式会社 貧血の予防又は治療用組成物
CN101869141B (zh) 2010-05-25 2012-07-25 北京三元食品股份有限公司 强化铁、锌和钙的咸味酸奶及其加工方法
CN102144670A (zh) 2011-02-28 2011-08-10 澳优乳业（中国）有限公司 一种益生菌配方奶粉及其制造方法
EP2534959A1 (en) 2011-06-14 2012-12-19 Nestec S.A. Wholegrain cereal and liver disorders
US20130095204A1 (en) 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
US20130095189A1 (en) 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
SG11201405917UA (en) 2012-03-21 2014-11-27 Yakult Honsha Kk Iron pyrophosphate composition
CN102940037B (zh) 2012-05-23 2014-06-04 四川农业大学 制备共沉淀氢氧化铁酸奶的方法
CN103988863B (zh) 2013-02-20 2016-12-28 湖北智权专利技术应用开发有限公司 一种具有保健功能的低热量、高营养烘焙食品
WO2014148886A1 (en) * 2013-03-22 2014-09-25 N.V. Nutricia Fermented nutrition high in lactose with increased iron bioavailability
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
CN106030311B (zh) 2014-02-17 2019-10-18 雀巢产品有限公司 线粒体融合蛋白的方法和用途

Also Published As

Publication number Publication date
EP3307290B1 (en) 2020-04-15
ES2803175T3 (es) 2021-01-25
BR112017023636B1 (pt) 2021-11-03
CN107690332A (zh) 2018-02-13
WO2016198528A1 (en) 2016-12-15
US11660322B2 (en) 2023-05-30
MX2017015674A (es) 2018-04-18
US20180133267A1 (en) 2018-05-17
US20230381252A1 (en) 2023-11-30
CA2983685A1 (en) 2016-12-15
PH12017502042A1 (en) 2018-04-23
EP3307290A1 (en) 2018-04-18

Similar Documents

Publication Publication Date Title
BR112017023636A2 (pt) suplemento dietético
MX2021007668A (es) Composiciones que comprenden cepas bacterianas.
CL2018001358A1 (es) Composiciones que comprenden cepas bacterianas
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
BR112017026241A2 (pt) composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas
EP3583219A4 (en) PROBIOTIC COMPOSITIONS AND USES THEREFORE
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
BR112017008670A2 (pt) película oral de dexametasona
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
BR112016023752A2 (pt) utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose
SG11201608730UA (en) Bifidobacterium breve cbt br3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
TW201613624A (en) Use of lactobacillus reuteri GMNL-263 for manufacturing composition for increasing expression of LDL-R and CYP7A1 in liver in high-fat diet individual
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
IN2014DN06617A (pt)
FI20096400A0 (fi) Veriryhmästatuksen käyttö I
BR112015005355A2 (pt) composição prebiótica de tilacoíde
AR106769A1 (es) Composiciones que comprenden cepas bacterianas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/06/2016, OBSERVADAS AS CONDICOES LEGAIS.